Head-To-Head Comparison: Mitesco (OTCMKTS:MITI) & Zepp Health (NYSE:ZEPP)

Zepp Health (NYSE:ZEPP) and Mitesco (OTCMKTS:MITI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

Insider and Institutional Ownership

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 0.0% of Mitesco shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Comparatively, 4.9% of Mitesco shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Zepp Health and Mitesco, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1	0	1	0	2.00
Mitesco	0	0	0	0	0.00

Zepp Health currently has a consensus target price of $64.37, suggesting a potential upside of 120.88%. Given Zepp Health’s stronger consensus rating and higher probable upside, analysts plainly believe Zepp Health is more favorable than Mitesco.

Valuation and Earnings

This table compares Zepp Health and Mitesco”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$182.60 million	2.31	-$75.73 million	($4.11)	-7.09
Mitesco	$40,000.00	55.81	-$2.51 million	($0.14)	-1.06

Mitesco has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Zepp Health and Mitesco’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zepp Health	-28.28%	-21.45%	-9.20%
Mitesco	1,639.45%	N/A	-744.83%

Volatility & Risk

Zepp Health has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Mitesco has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.